Prosecution Insights
Last updated: August 16, 2026
Application No. 18/697,116

PROGRAMMABLE SELECTIVE ACYLATION OF POLYOLS

Non-Final OA §102§103§112
Filed
Mar 29, 2024
Priority
Oct 05, 2021 — SG 10202111103X +1 more
Examiner
MILLER, DALE R
Art Unit
Tech Center
Assignee
Nanyang Technological University
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
2m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
451 granted / 723 resolved
+2.4% vs TC avg
Strong +17% interview lift
Without
With
+17.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
32 currently pending
Career history
751
Total Applications
across all art units

Statute-Specific Performance

§101
5.1%
-34.9% vs TC avg
§103
47.0%
+7.0% vs TC avg
§102
20.3%
-19.7% vs TC avg
§112
14.6%
-25.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 723 resolved cases

Office Action

§102 §103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Pursuant to the preliminary amendment dated 3/29/2024, claims 1-3, 7-12, 14 and 15 are amended and claims 16 and 17 are newly added. Claims 1-17 are pending in the instant application and are examined on the merits herein. Priority This application is a National Stage Application of PCT/SG2022/050711, filed on 10/5/2022. The instant application claims foreign priority to SG 10202111103X filed on 10/5/2021. Acknowledgment is made of applicant's claim for foreign priority under 35 U.S.C. 119(a)-(d). The certified copy has been filed in the instant application on 3/29/2024. Information Disclosure Statement The information disclosure statements (IDS) dated 3/29/2024 comply with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609, except where noted. Accordingly, the IDS documents have been placed in the application file and the information therein has been considered as to the merits. Claim Rejections - 35 USC § 112—Second Paragraph The following is a quotation of 35 U.S.C. 112(b): (B) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claim 11 is rejected for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. The compound at row 1, column 3 of claim 11 is associated with the phrase “and more particularly”. This phrase renders the claim indefinite because it is unclear whether the limitation(s) following the phrase are part of the claimed invention. Preferences, options and examples are properly set forth in the specification, but when included in the claims lead to confusion over the intended scope of the claim. See MPEP § 2173.05(d). For examination purposes, the broadest claim limitation(s) will be considered without taking into account preferences or examples. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 2, 5-10, 12, 13 and 15 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Cramer et al. (Chem. Eur. J., 2016, IDS). Cramer et al. discloses a selective acylation of carbohydrates, exemplified by the following reaction, with particular note of entries 7-10 performed at 55°C: (Table 2) PNG media_image1.png 614 579 media_image1.png Greyscale In Table 2 of Cramer: “3” = PNG media_image2.png 84 158 media_image2.png Greyscale , which is an oxidant; “D” and “F” are N-heterocyclic carbene (NHC) precatalysts, as depicted among the following NHC options: (Figure 1) PNG media_image3.png 353 550 media_image3.png Greyscale ; and “DBU” = PNG media_image4.png 166 285 media_image4.png Greyscale , which is both a base and a coupling agent. Cramer also discloses that excellent selectivity was observed for carbohydrate derivatives containing multiple free OH groups. Notably, this transformation is amenable to both cis/trans 2,3-diols of the glucose, mannose, and galactose series. (p. 7406, Col. 1) Accordingly, the instant claims are anticipated by the prior art. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 3, 4 and 17 are rejected under 35 U.S.C. 103 as being unpatentable over Cramer et al. (Chem. Eur. J., 2016, IDS). The disclosure of Cramer is referenced as discussed above. Cramer does not exemplify the claimed polyols. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to expand upon the exemplified embodiment of Cramer to include other carbohydrates such as those of the glucose, mannose, and galactose series, because Cramer concludes that the synthetic approach disclosed is broadly applicable to these carbohydrates as well. In addition, one of ordinary skill in the art could envision deprotecting the 6 position, to cleave the TIPS group, of the exemplified compound 1 of Cramer, which would yield a carbohydrate starting material identical to the first two entries in the table of instant claim 4. Accordingly, the instant claims are prima facie obvious over the teachings of the prior art. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Cramer et al. (Chem. Eur. J., 2016, IDS), in view of Ragano et al. (ACS Sust. Chem. Eng., June 2021, PTO-892). The disclosure of Cramer is referenced as discussed above. Cramer does not teach the claimed acylating agents. Ragano et al. discloses selective acylation of polyols using NHC chemistry where multiple acylation reagents were studied, as tabulated below: (Table 3) PNG media_image5.png 969 399 media_image5.png Greyscale It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to expand upon the exemplified embodiment of Cramer to employ other art recognized acylation reagents used in NHC chemistry of polyols, thereby arriving at the instant invention. One would look to Ragano, as analogous art, for guidance on the types of acylation reagents that would reasonably be art-recognized. Accordingly, the instant claims are prima facie obvious over the teachings of the prior art. Claims 14 and 16 are rejected under 35 U.S.C. 103 as being unpatentable over Cramer et al. (Chem. Eur. J., 2016, IDS), in view of DeSarkar et al. (Chem. Eur. J., 2013, PTO-892). The disclosure of Cramer is referenced as discussed above. Cramer does not teach the use of a boronic acid. DeSarkar et al. discloses that NHC chemistry can be modified with the inclusion of alkyl boronic acids, as oxidants, to generate a boronic acid-NHC adduct which can be used for esterification reactions. (Scheme 11) PNG media_image6.png 227 385 media_image6.png Greyscale It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention that the reaction of Cramer could be modified with the addition of a boronic acid, such as taught by DeSarkar, thereby arriving at the instant invention. One would look to DeSarkar, as analogous art, for guidance on art-recognized modifications to the oxidant in NHC chemistry which would be equivalent to the oxidant of Cramer. Accordingly, the instant claims are prima facie obvious over the teachings of the prior art Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DALE R MILLER whose telephone number is (571) 272-6146. The examiner can normally be reached on M-F 7:00 AM – 3:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached on (571) 270-5341. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from Patent Center and the Private Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from Patent Center or Private PAIR. Status information for unpublished applications is available through Patent Center and Private PAIR to authorized users only. Should you have questions about access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). /DALE R MILLER/Primary Examiner, Art Unit 1693
Read full office action

Prosecution Timeline

Mar 29, 2024
Application Filed
Aug 04, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12698397
COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL
2y 6m to grant Granted Aug 04, 2026
Patent 12685741
N-ACETYLNEURAMINIC ACID COMPOSITIONS AND METHODS OF USE
6y 3m to grant Granted Jul 21, 2026
Patent 12679861
PHOTOISOMERIZED COMPOSITIONS OF ANTHOCYANINS AND METHODS OF MAKING AND USE THEREOF
4y 0m to grant Granted Jul 14, 2026
Patent 12673968
MODIFIED GUANINES
2y 10m to grant Granted Jul 07, 2026
Patent 12661366
OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING VIRAL INFECTIONS
3y 8m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
80%
With Interview (+17.4%)
2y 7m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 723 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month